However, as the extent of fibrosis increased, specificity rose from 43.8 to 92.7%, implying that WFA+-M2BP may be useful in detecting advanced fibrosis or cirrhosis, regardless of the inferiority displayed overall. The gene discussed is LGALS3BP; the disease is fibrosis.